Point72 Asset Management’s Zura Bio ZURA Stock Holding History
Bought
Maintained
Sold
Other funds holding ZURA
SCM
VA
GPP
B
SL
CC
P
AAA
Point72 Asset Management's ZURA Position: Q1 2026 in Review
Point72 Asset Management increased its Zura Bio (ZURA) stake by 285% in Q1 2026, buying an estimated $3.9M and bringing the position to 872,662 shares worth $5.19M. The position accounts for 0.01% of the portfolio, ranked #1684.
Point72 Asset Management first reported a position in ZURA in Q2 2023 and has held it in 10 quarters since. The position peaked at $9.8M in Q3 2024. 94 funds tracked by Wall St. Rank hold ZURA as of Q1 2026.
- Point72 Asset Management held 872,662 shares of Zura Bio worth $5.19M as of Q1 2026.
- Point72 Asset Management bought 645,829 Zura Bio shares in Q1 2026, an estimated $3.9M.
- Zura Bio made up 0.01% of Point72 Asset Management's portfolio in Q1 2026, its #1684 holding.
- Point72 Asset Management first reported a position in Zura Bio in Q2 2023 and has held it in 10 quarters since.
- Point72 Asset Management's Zura Bio position peaked at $9.8M in Q3 2024.
- 94 funds tracked by Wall St. Rank held Zura Bio as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.